Terms: = Brain cancer AND HOXD13, SPD, 3239, P35453, HOX4I AND Prognosis
5 results:
1. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract] [Full Text] [Related]
2. The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes.
Ding XC; Wang LL; Zhu YF; Li YD; Nie SL; Yang J; Liang H; Weichselbaum RR; Yu JM; Hu M
Front Immunol; 2020; 11():580335. PubMed ID: 33224142
[TBL] [Abstract] [Full Text] [Related]
3. CD24 and PRAME Are Novel Grading and Prognostic Indicators for Pineal Parenchymal Tumors of Intermediate Differentiation.
Wu X; Wang W; Lai X; Zhou Y; Zhou X; Li J; Liang Y; Zhu X; Ren X; Ding Y; Liang L
Am J Surg Pathol; 2020 Jan; 44(1):11-20. PubMed ID: 31567202
[TBL] [Abstract] [Full Text] [Related]
4. Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study.
Choi YY; Kim H; Shin SJ; Kim HY; Lee J; Yang HK; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Choi SH; Hong S; Kim JW; Hyung WJ; Noh SH; Cheong JH
Ann Surg; 2019 Aug; 270(2):309-316. PubMed ID: 29727332
[TBL] [Abstract] [Full Text] [Related]
5. DNA methylation profiles of long- and short-term glioblastoma survivors.
Shinawi T; Hill VK; Krex D; Schackert G; Gentle D; Morris MR; Wei W; Cruickshank G; Maher ER; Latif F
Epigenetics; 2013 Feb; 8(2):149-56. PubMed ID: 23291739
[TBL] [Abstract] [Full Text] [Related]